ALEXANDRIA REAL ESTATE EQ IN shareholders Q2 2023

ALEXANDRIA REAL ESTATE EQ IN's ticker is ARE and the CUSIP is 015271109. A total of 581 filers reported holding ALEXANDRIA REAL ESTATE EQ IN in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

ALEXANDRIA REAL ESTATE EQ IN shareholders Q2 2023
Name	Shares	Value	Weighting ↓
Gradient Investments LLC	221,300	$25,115,299	0.65%
BRASADA CAPITAL MANAGEMENT, LP	24,731	$2,806,721	0.61%
Credit Capital Investments LLC	3,966	$450,101	0.59%
Leeward Investments, LLC - MA	108,049	$12,262,481	0.58%
DUFF & PHELPS INVESTMENT MANAGEMENT CO	402,209	$45,646,699	0.56%
Capital Square, LLC	5,258	$596,805	0.55%
ALETHEA CAPITAL MANAGEMENT, LLC	4,501	$510,818	0.55%
BOWEN HANES & CO INC	150,000	$17,023,500	0.54%
Seaport Global Advisors, LLC	1,632	$185,216	0.54%
THOMPSON INVESTMENT MANAGEMENT, INC.	29,317	$3,327,186	0.54%
Bridgefront Capital, LLC	8,109	$920,290	0.50%
PRINCIPAL FINANCIAL GROUP INC	6,417,616	$728,340,041	0.50%
VICTORY CAPITAL MANAGEMENT INC	3,866,714	$438,833,372	0.48%
Motley Fool Wealth Management, LLC	67,804	$7,714,074	0.46%
Malaga Cove Capital, LLC	7,823	$887,832	0.41%
Core Alternative Capital	23,705	$2,690,322	0.39%
BRAUN STACEY ASSOCIATES INC	73,978	$8,395,763	0.39%
BAMCO INC /NY/	1,148,733	$130,369,708	0.36%
SHERBROOKE PARK ADVISERS LLC	6,000	$680,940	0.36%
CTC Alternative Strategies, Ltd.	2,510	$284,860	0.36%

About ALEXANDRIA REAL ESTATE EQ IN

Alexandria Real Estate Equities, Inc. (ARE) is a real estate investment trust (REIT) that specializes in the ownership, operation, and development of life science and technology properties. The company is headquartered in Pasadena, California, and has a portfolio of over 33 million square feet of rentable space across key innovation clusters in the United States, Canada, and the United Kingdom.

ARE's focus on life science and technology properties has proven to be a wise investment strategy, as the demand for these types of properties has increased in recent years. The company's properties are home to some of the world's leading pharmaceutical, biotechnology, and technology companies, making it a key player in the industry.

In addition to its impressive portfolio, ARE has a strong financial position, with a market capitalization of over $30 billion and a debt-to-equity ratio of just 0.67. The company has also consistently delivered strong financial results, with a 5-year average revenue growth rate of 16.5% and a 5-year average return on equity of 6.9%.

ARE's leadership team is also impressive, with Joel Marcus serving as the company's Executive Chairman and Peter Moglia as its Chief Financial Officer. Both Marcus and Moglia have extensive experience in the real estate industry and have been instrumental in the company's success.

Overall, Alexandria Real Estate Equities, Inc. is a strong player in the life science and technology real estate market, with a solid portfolio, strong financials, and experienced leadership team. Investors looking for exposure to this growing industry may want to consider adding ARE to their portfolios.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists ALEXANDRIA REAL ESTATE EQ IN's shareholders in Q2 2023. To view ALEXANDRIA REAL ESTATE EQ IN's shareholder history, click here.